Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ASXC..............................https://stockcharts.com/h-sc/ui?s=ASXC&p=W&b=5&g=0&id=p86431144783
There really wasn’t any other option for this great technology to survive.
Some signs of life in the 4th Q. Still thinking $35 million is the breakeven point. Also noticed that after this January expiration date, the lowest option strike price is $2.50. I have never seen that happen before so I think it has something to do with a reverse split to get the stock price into compliance.
ASXC...READY FOR 42C COMING OUT OF WEELY PINCH
They need to sell out. They have a great product that isn’t selling. Why? Because customers fear they won’t survive.
Does ASXC have a future?
ASXC Stock 12 Months Forecast
Based on 2 Wall Street analysts offering 12 month price targets for Asensus Surgical in the last 3 months. The average price target is $1.50 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 536.67% change from the last price of $0.24. :)
Not a big holder either but I see that the inner circle sees something that we do not. :)
I own very few shares and I am wondering if a reverse split could leave me with no shares. I have not seen any SEC filings lately.
Asensus Surgical Announces Collaboration with NVIDIA to Enhance Augmented Intelligence Capabilities of the ISU
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced a collaboration with NVIDIA to accelerate the development of Asensus’s Intelligent Surgical Unit™ (ISU™) and improve its ability to deliver novel clinical intelligence to surgeons.
Asensus will utilize a broad suite of NVIDIA tools to enhance the augmented intelligence capabilities of its ISU. Asensus’s ISU is built with NVIDIA accelerated computing technology and has been bringing real-time augmented intelligent features — such as digital tags, 3D measurement, and enhanced camera control — to surgeons since 2021.
“We’re thrilled to collaborate with NVIDIA to enhance the machine vision and image analytics capabilities of the ISU, as well as the processing speed and precision of its augmented intelligence capabilities. Utilizing NVIDIA’s advanced technologies will allow us to further improve the ISU’s augmented intelligence capabilities and the roadmap of our innovative clinical applications,” said Anthony Fernando, Asensus Surgical President and CEO. “Through this collaboration, Asensus is furthering its vision to enhance clinical intelligence in surgery through the use of advanced augmented intelligence tools.”
As part of the collaboration, both companies will have early access to relevant product roadmaps, fostering synergistic development. Furthermore, Asensus and NVIDIA plan to jointly define innovative business models for the development, deployment, and commercialization of digital surgical solutions.
“The healthcare industry, and in particular digital surgery, is becoming one of the largest data generating industries. NVIDIA brings a domain-specific full stack edge AI computing platform, Holoscan, to medtech innovators looking to optimize real-time data and image processing to help solve complex problems and improve surgeon decision-making,” said David Niewolny, Director of Healthcare Business Development at NVIDIA. “As a leading FDA cleared solution in soft-tissue abdominal surgery, Asensus’s ISU is a perfect platform to leverage NVIDIA’s software-defined architecture to accelerate innovation and deliver new products to surgeons faster via software-as-a-medical-device applications.”
Bought a few just going to hold these
$ASXC - Announces $10 Million Registered Direct Offering
Working on closing business combination
w/ KARL STORZ VentureONE Pte. Ltd
Up 10% Pre-Market/ Current Price $0.34
Moving up nice and steady.
ASXC
More news: Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms
https://ir.asensus.com/news-releases/news-release-details/asensus-and-karl-storz-market-intelligent-surgical-unit-and-co
ASXC
News: Collaboration with Google Cloud for Surgery. Interesting.
ASXC
Big day today! CE Mark additional approval. Breakeven seems to be above $35 million a year.
70s and dumping, lmfao.
Cantor Fitzgerald sticks their necks out with an overweight rating and a $1.50 target.
What level of revenue is needed to reach positive cash flow? I think the number is around $40 million. They have a long way to go!
I doubt ASXC will be below $3 much longer
SUPER BUY ASXC is an understatement
With placement in Japan and Russia last week we are moving up soon
SUPER BUY ASXC
Soon their SENHANCE surgical units are going to be in a number of US HOSPITALS side by side with Da Vinci. SENHANCE is the safest most sophisticated Robotic AI AR vision tracking surgical platform developed since Da Vinci came to market some 20 years ago.
Smells like a buy out will happen here soon if not def a M/A
Go back to sleep. I am out.
* * $ASXC Video Chart 06-04-2021 * *
Link to Video - click here to watch the technical chart video
* * $ASXC Video Chart 06-03-2021 * *
Link to Video - click here to watch the technical chart video
Any news?
Holding 30,000 shares here. Big things to come!
* * $ASXC Video Chart 05-26-2021 * *
Link to Video - click here to watch the technical chart video
* * $ASXC Video Chart 05-18-2021 * *
Link to Video - click here to watch the technical chart video
Earnings Tuesday... then up to $6 or back to $.60. Any ideas?
Followers
|
177
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7901
|
Created
|
10/20/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |